Trademark Overview
On Tuesday, June 3, 2025, a trademark application was filed for AMLYPAVE with the United States Patent and Trademark Office. The USPTO has given the AMLYPAVE trademark a serial number of 99216119. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, November 3, 2025. This trademark is owned by Alexion Pharmaceuticals, Inc.. The AMLYPAVE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of infection, inflammation, hematological, and autoimmune related diseases and disorders; Antibodies for medical purposes; Vaccines; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems